for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Divi's Laboratories Ltd

DIVI.NS

Latest Trade

4,179.40INR

Change

-150.35(-3.47%)

Volume

1,172,704

Today's Range

4,137.80

 - 

4,328.30

52 Week Range

3,153.30

 - 

5,425.10

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

SMS Pharma Says "Strongly Condemn" News On Divis Labs Buying Co's Stake

Sept 16 (Reuters) - Sms Pharmaceuticals Ltd <SMSP.NS>::"STRONGLY CONDEMN" NEWS ON DIVIS LABRATORIES ACQUIRING STAKE IN CO.

Divi's Labs Currently Experiencing Some Supply Chain Disruptions During India Lockdown Period

April 1 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::CURRENTLY EXPERIENCING SOME SUPPLY CHAIN DISRUPTIONS DURING INDIA LOCKDOWN PERIOD.ANTICIPATE CERTAIN DELAYS IN DELIVERIES OF CO'S PRODUCTS TO CO'S CUSTOMERS.

India's Divi's Labs Dec-Quarter Profit Falls

Feb 5 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::DEC-QUARTER CONSOL PROFIT 3.59 BILLION RUPEES VERSUS 3.90 BILLION RUPEES YEAR AGO.DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 13.96 BILLION RUPEES VERSUS 13.60 BILLION RUPEES YEAR AGO.

Divi's Laboratories Says FDA Inspection Of Unit II At Village Chippada, Andhra Pradesh

Jan 31 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::DIVI'S LABORATORIES LTD SAYS - US-FDA INSPECTION OF UNIT -II AT VILLAGE CHIPPADA, ANDHRA PRADESH.DIVI'S LABORATORIES LTD SAYS INSPECTION HAS BEEN CONCLUDED WITH NO '483'OBSERVATIONS..

India's Divi's Laboratories Sept Quarter Consol Net Profit Falls

Nov 5 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::SEPT QUARTER CONSOL NET PROFIT 3.57 BILLION RUPEES VERSUS 4.04 BILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 14.46 BILLION RUPEES VERSUS 13.24 BILLION RUPEES YEAR AGO.

India's Divi's Labs Says Inspected By HPRA (Ireland), JAZMP (Slovenia)

Aug 30 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::INDIA'S DIVI'S LABORATORIES SAYS HAS BEEN INSPECTED BY 5 INSPECTORS FROM HPRA (IRELAND) AND JAZMP (SLOVENIA) FROM 26TH AUGUST, 2019 TO 30TH AUG.SAYS INSPECTION AT SITE WAS FOCUSED ON GENERAL GMP; INSPECTION CONCLUDED SUCCESSFULLY WITH NO CRITICAL OBSERVATIONS.

India's Divi's Laboratories Says No Irregularities Found Post Income Tax Search Operation

Feb 19 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::SAYS TAX OFFICIALS CONDUCTED SEARCH AT CO'S HEAD OFFICE, RESEARCH CENTRE, MANUFACTURING SITES FROM FEB 14 TO 18.SAYS NO IRREGULARITIES HAVE BEEN FOUND POST SEARCH OPERATION.

Divi's Laboratories Says Search Enquiry By Tax Officials Continuing

Feb 15 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::DIVI'S LABORATORIES -TAX OFFICIALS VISITED HEAD OFFICE, MANUFACTURING SITES IN CONNECTION WITH SEARCH ON FEB 14; SEARCH ENQUIRY IS CONTINUING.

Divi's Labs Says US FDA Inspects Unit-I At Telangana From May 14 To May 16

May 16 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::SAYS UNIT-I AT CHOUTUPPAL, TELANGANA STATE HAS HAD AN INSPECTION BY US-FDA FROM 14TH MAY TO 16TH MAY.WAS A GENERAL CGMP INSPECTION BY FDA.SAYS INSPECTION HAS BEEN CONCLUDED WITH NO 483 OBSERVATIONS.

Divi's Laboratories says US FDA's import alert on unit II at Vishakhapatnam removed‍​

Nov 15 (Reuters) - Divi's Laboratories Ltd <DIVI.NS>::Says US FDA's import alert 66-40 on co's unit II at Vishakhapatnam has been removed‍​.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up